nandrolone has been researched along with Adenoma, Prostatic in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (63.64) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acevedo, C; Cabezas, J; Castellón, EA; Contreras, HR; Huidobro, C; Mendoza, P; Noé, G; Sánchez, C; Vergara, J | 1 |
| Abreu, GR; Alcure, SM; Andrade, TU; Bissoli, NS; Lenz, D; Loiola, LZ; Medeiros, AR; Moysés, MR; Santos, MC; Uggere de Andrade, T | 1 |
| Fujii, M; Fujiwara, H; Kitano, T; Kodama, M; Matsuki, S; Nihira, H; Sagami, K; Tado, O; Ukai, R; Yasukawa, A | 1 |
| Iguchi, H; Ikeuchi, T; Kai, Y; Yoshida, H | 1 |
| Collins, AT; Gilmore, K; Neal, DE; Zhiming, B | 1 |
| Collins, AT; Neal, DE; Robinson, EJ | 1 |
| Bartsch, G; Frick, J; Rohr, HP | 1 |
| Carruba, G; Castagnetta, L; Cusimano, R; Fecarotta, E; Lo Casto, M; Pavone-Macaluso, M | 1 |
| Fuse, H; Ishikawa, S; Katayama, T; Kazama, T; Mizuno, I; Takamine, T; Terada, T; Umeda, K | 1 |
| Umeda, K | 1 |
| Akimoto, S; Fuse, H; Sato, R; Shimazaki, J; Zama, S | 1 |
| Müller, RE; Traish, AM; Wotiz, HH | 1 |
| Johnson, MP; Murthy, LR; Rowley, DR; Scardino, PT; Tindall, DJ; Young, CY | 1 |
| Böttger, I; Reidel, G; Schiessl, J; Schütz, W; Schwemmer, B | 1 |
| Bashirelahi, N; Ekiko, DB; Ganesan, S; Shida, K; Takahashi, E; Yamanaka, H; Young, JD | 1 |
| Aoyama, T; Furuya, S; Honma, A; Kumamoto, Y; Miyamoto, S; Takagi, Y; Takatsuka, K; Tamiya, T; Tsukamoto, T; Yokoyama, E | 1 |
| Kawase, M; Nakayama, R; Oishi, K; Okada, K; Sudo, K; Yoshida, O | 2 |
| Andersson, T; Frimodt-Møller, C; Lindgård, G; Meyhoff, HH; Nielsen, MS; Ostri, P; Petersen, JH; Swartz, R | 1 |
| Hansson, V; Tveter, KJ | 1 |
| Haugen, OA | 1 |
| Farnsworth, WE | 1 |
2 trial(s) available for nandrolone and Adenoma, Prostatic
| Article | Year |
|---|---|
[Clinical efficacy of oxendolene (antiandrogen) and bunazosin hydrochloride (alpha-adrenergic blocker) in the treatment of prostatism--comparative study of oxendolone, bunazocin hydrochloride and their combination].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androgen Antagonists; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nandrolone; Prostatic Hyperplasia; Quinazolines; Urinary Bladder Neck Obstruction; Urination | 1987 |
Antiandrogenic treatment of benign prostatic hyperplasia: a placebo controlled trial.
Topics: Aged; Androgen Antagonists; Double-Blind Method; Humans; Male; Multicenter Studies as Topic; Nandrolone; Prospective Studies; Prostatic Hyperplasia; Random Allocation; Urination | 1989 |
20 other study(ies) available for nandrolone and Adenoma, Prostatic
| Article | Year |
|---|---|
Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
Topics: Androgens; Dihydrotestosterone; Finasteride; Humans; Male; Nandrolone; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Testosterone; Testosterone Congeners | 2009 |
Role of the renin-angiotensin system in the nandrolone-decanoate-induced attenuation of the Bezold-Jarisch reflex.
Topics: Anabolic Agents; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bradycardia; Cardiomegaly; Enalapril; Heart Rate; Male; Nandrolone; Nandrolone Decanoate; Prostatic Hyperplasia; Rats, Wistar; Renin-Angiotensin System | 2011 |
[Clinical experience with oxendolone for treatment of benign prostatic hyperplasia. Clinical efficacy and effects on serum lipid and lipoprotein fraction levels].
Topics: Aged; Androgen Antagonists; Drug Evaluation; Humans; Lipids; Lipoproteins; Male; Middle Aged; Nandrolone; Prostatic Hyperplasia | 1984 |
[Influence of anti-androgen therapy for prostatic hypertrophy on lipid metabolism].
Topics: Aged; Aged, 80 and over; Allylestrenol; Androgen Antagonists; Chlormadinone Acetate; Gestonorone Caproate; Humans; Lipid Metabolism; Lipids; Lipoproteins, HDL; Male; Malondialdehyde; Middle Aged; Nandrolone; Prostatic Hyperplasia | 1994 |
Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor.
Topics: Cells, Cultured; Estradiol; Humans; Male; Nandrolone; Prostate; Prostatic Hyperplasia; Protein Binding; Receptors, Androgen; Stimulation, Chemical; Tamoxifen; Testosterone Congeners | 1994 |
Benign prostatic stromal cells are regulated by basic fibroblast growth factor and transforming growth factor-beta 1.
Topics: Cell Division; Cell Separation; Cells, Cultured; DNA; Epithelium; Fibroblast Growth Factor 2; Flow Cytometry; Humans; Male; Nandrolone; Prostate; Prostatic Hyperplasia; Testosterone Congeners; Transforming Growth Factor beta | 1996 |
Stereology, a new morphological method of study prostatic function and disease.
Topics: Adult; Animals; Biopsy, Needle; Estradiol Congeners; Humans; Male; Methods; Muscle, Smooth; Nandrolone; Progesterone Congeners; Prostate; Prostatectomy; Prostatic Diseases; Prostatic Hyperplasia; Rats | 1976 |
Soluble and nuclear type I and II androgen-binding sites in benign hyperplasia and cancer of the human prostate.
Topics: Aged; Binding Sites; Humans; Male; Nandrolone; Predictive Value of Tests; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Radioligand Assay; Receptors, Androgen; Testosterone Congeners; Tritium | 1992 |
[Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography].
Topics: Administration, Oral; Androgen Antagonists; Chlormadinone Acetate; Humans; Injections, Intramuscular; Male; Nandrolone; Prostate; Prostatic Hyperplasia; Ultrasonography | 1990 |
[Clinical results and problems of anti-androgen therapy of benign prostatic hypertrophy].
Topics: Administration, Oral; Aged; Allylestrenol; Androgen Antagonists; Chlormadinone Acetate; Humans; Injections, Intramuscular; Male; Nandrolone; Prostatic Hyperplasia | 1991 |
Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881.
Topics: Cell Nucleus; Cytosol; Estrenes; Humans; Male; Metribolone; Nandrolone; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid | 1985 |
Binding of 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) to androgen and progesterone receptors in human and animal tissues.
Topics: Animals; Blood Proteins; Breast; Cattle; Cell Nucleus; Cytosol; Dihydrotestosterone; Estrenes; Female; Humans; Male; Metribolone; Nandrolone; Pregnenediones; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Progesterone; Substrate Specificity; Uterus | 1986 |
Characterization of steroid receptors in human prostate using mibolerone.
Topics: Animals; Chemical Phenomena; Chemistry; Dihydrotestosterone; Estrenes; Female; Humans; Male; Metribolone; Nandrolone; Promegestone; Prostate; Prostatic Hyperplasia; Rabbits; Receptors, Androgen; Receptors, Progesterone; Testosterone | 1986 |
Determination of androgen receptors in human benign prostatic hypertrophy with two synthetic radiolabeled ligands.
Topics: Cell Nucleus; Cytoplasm; Cytosol; Epithelium; Estrenes; Humans; Male; Metribolone; Nandrolone; Promegestone; Prostate; Prostatic Hyperplasia; Radioligand Assay; Receptors, Androgen; Receptors, Progesterone; Testosterone Congeners | 1986 |
Effect of 16 beta-ethyl-17 beta-hydroxy-4-estren-3-one (TSAA-291) on the binding of promegestone (R5020) and methyltrienolone (R1881) to hyperplastic and neoplastic human prostate.
Topics: Binding, Competitive; Centrifugation, Density Gradient; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Estrenes; Humans; Male; Mathematics; Metribolone; Nandrolone; Norpregnadienes; Promegestone; Prostatic Hyperplasia | 1986 |
Study of the effect of an anti-androgen (oxendolone) on experimentally induced canine prostatic hyperplasia. I. Morphological analysis.
Topics: Androstane-3,17-diol; Animals; Dogs; Estradiol; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Nandrolone; Prostate; Prostatic Hyperplasia; Testosterone | 1988 |
Study of the effect of an anti-androgen (oxendolone) on experimentally induced canine prostatic hyperplasia. II. Endocrinological analysis.
Topics: Animals; Dihydrotestosterone; Dogs; Estradiol; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Nandrolone; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Estrogen; Testosterone | 1988 |
Effect of anti-androgens on the uptake and binding of androgen by human benign nodular prostatic hyperplasia in vitro.
Topics: Cell Nucleus; Chromatography; Chromatography, Gel; Cytoplasm; Humans; In Vitro Techniques; Male; Nandrolone; Prednisolone; Pregnanes; Prostatic Hyperplasia; Testosterone; Tritium | 1971 |
Distribution of pituitary cell types in relation to the histology of the prostate in elderly men. An analysis in an autopsy series.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Atrophy; Autopsy; Body Height; Body Weight; Diabetes Mellitus; Estrogens; Humans; Liver Cirrhosis; Male; Middle Aged; Nandrolone; Periodic Acid; Pituitary Gland; Prostate; Prostatectomy; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Regression Analysis; Staining and Labeling | 1973 |
10-Demethylation of testosterone by human prostate, in vitro.
Topics: Humans; In Vitro Techniques; Male; Nandrolone; Prostate; Prostatic Hyperplasia; Testosterone | 1965 |